Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Laboratorios Leti, S.L.
Immunotherapy is a specific treatment for allergic diseases. Unlike conventional pharmacological treatment, immunotherapy is the only treatment that could modify the natural course of allergic disease. This is a prospective double-blind placebo controlled study with three arms of treatment: placebo and two active (one of the active arms will receive a dose that is 10x the dose of the other arm).
Age
12–50
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Positive clinical history of allergy to Phleum pratense
Patients of both gender aged from 12 up to 50 years.
Positive prick test to Phleum pratense allergen extracts
Specific IgE to Phleum pratense
Positive clinical history of allergic rhinoconjunctivitis and/or asthma
Written informed consent.
You may not be if
Use of immunotherapy during the last four years.
Any contraindication for the use of immunotherapy in accordance with European Allergy and Clinical Immunology Immunotherapy Subcommittee criteria:
Treatment with ß-blockers
Coexistence of immunopathological diseases (e.g. of the liver, kidney, the nervous system, thyroid gland, rheumatic diseases) in which autoimmune mechanisms play a role
Patients suffering from immune deficiencies
Patients with serious psychiatric / psychological disturbances
Pregnant or/ in lactation patients
Patients aspirin intolerance
Clareo Health | Immunotherapy With Depigmented and Polymerized Allergen Extract of Phleum Pratense
